123 related articles for article (PubMed ID: 12851929)
1. Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurG.
Liu H; Ritter TK; Sadamoto R; Sears PS; Wu M; Wong CH
Chembiochem; 2003 Jul; 4(7):603-9. PubMed ID: 12851929
[TBL] [Abstract][Full Text] [Related]
2. Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.
Helm JS; Hu Y; Chen L; Gross B; Walker S
J Am Chem Soc; 2003 Sep; 125(37):11168-9. PubMed ID: 16220917
[TBL] [Abstract][Full Text] [Related]
3. The biosynthesis of peptidoglycan lipid-linked intermediates.
Bouhss A; Trunkfield AE; Bugg TD; Mengin-Lecreulx D
FEMS Microbiol Rev; 2008 Mar; 32(2):208-33. PubMed ID: 18081839
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurG.
Chen L; Men H; Ha S; Ye XY; Brunner L; Hu Y; Walker S
Biochemistry; 2002 May; 41(21):6824-33. PubMed ID: 12022887
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.
Hu Y; Helm JS; Chen L; Ginsberg C; Gross B; Kraybill B; Tiyanont K; Fang X; Wu T; Walker S
Chem Biol; 2004 May; 11(5):703-11. PubMed ID: 15157881
[TBL] [Abstract][Full Text] [Related]
6. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.
Branstrom AA; Midha S; Longley CB; Han K; Baizman ER; Axelrod HR
Anal Biochem; 2000 May; 280(2):315-9. PubMed ID: 10790316
[TBL] [Abstract][Full Text] [Related]
7. The essential peptidoglycan glycosyltransferase MurG forms a complex with proteins involved in lateral envelope growth as well as with proteins involved in cell division in Escherichia coli.
Mohammadi T; Karczmarek A; Crouvoisier M; Bouhss A; Mengin-Lecreulx D; den Blaauwen T
Mol Microbiol; 2007 Aug; 65(4):1106-21. PubMed ID: 17640276
[TBL] [Abstract][Full Text] [Related]
8. A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesis.
Barbosa MD; Ross HO; Hillman MC; Meade RP; Kurilla MG; Pompliano DL
Anal Biochem; 2002 Jul; 306(1):17-22. PubMed ID: 12069409
[TBL] [Abstract][Full Text] [Related]
9. Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis.
Helm JS; Chen L; Walker S
J Am Chem Soc; 2002 Nov; 124(47):13970-1. PubMed ID: 12440876
[TBL] [Abstract][Full Text] [Related]
10. A fluorescent analogue of UDP-N-acetylglucosamine: application for FRET assay of peptidoglycan translocase II (MurG).
Li JJ; Bugg TD
Chem Commun (Camb); 2004 Jan; (2):182-3. PubMed ID: 14737539
[TBL] [Abstract][Full Text] [Related]
11. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
[TBL] [Abstract][Full Text] [Related]
12. A MurG assay which utilises a synthetic analogue of lipid I.
Auger G; van Heijenoort J; Mengin-Lecreulx D; Blanot D
FEMS Microbiol Lett; 2003 Feb; 219(1):115-9. PubMed ID: 12594032
[TBL] [Abstract][Full Text] [Related]
13. Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?
Henrichfreise B; Schiefer A; Schneider T; Nzukou E; Poellinger C; Hoffmann TJ; Johnston KL; Moelleken K; Wiedemann I; Pfarr K; Hoerauf A; Sahl HG
Mol Microbiol; 2009 Sep; 73(5):913-23. PubMed ID: 19656295
[TBL] [Abstract][Full Text] [Related]
14. E. Coli MurG: a paradigm for a superfamily of glycosyltransferases.
Ha S; Gross B; Walker S
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):201-13. PubMed ID: 12455415
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of analogues of bacterial lipid I.
Silva DJ; Bowe CL; Branstrom AA; Baizman ER; Sofia MJ
Bioorg Med Chem Lett; 2000 Dec; 10(24):2811-3. PubMed ID: 11133098
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
[TBL] [Abstract][Full Text] [Related]
17. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention.
Zawadzke LE; Wu P; Cook L; Fan L; Casperson M; Kishnani M; Calambur D; Hofstead SJ; Padmanabha R
Anal Biochem; 2003 Mar; 314(2):243-52. PubMed ID: 12654311
[TBL] [Abstract][Full Text] [Related]
18. An Alternative and Conserved Cell Wall Enzyme That Can Substitute for the Lipid II Synthase MurG.
Zhang L; Ramijan K; Carrión VJ; van der Aart LT; Willemse J; van Wezel GP; Claessen D
mBio; 2021 Apr; 12(2):. PubMed ID: 33824209
[TBL] [Abstract][Full Text] [Related]
19. Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.
Mann PA; Müller A; Xiao L; Pereira PM; Yang C; Ho Lee S; Wang H; Trzeciak J; Schneeweis J; Dos Santos MM; Murgolo N; She X; Gill C; Balibar CJ; Labroli M; Su J; Flattery A; Sherborne B; Maier R; Tan CM; Black T; Onder K; Kargman S; Monsma FJ; Pinho MG; Schneider T; Roemer T
ACS Chem Biol; 2013 Nov; 8(11):2442-51. PubMed ID: 23957438
[TBL] [Abstract][Full Text] [Related]
20. An assay for exogenous sources of purified MurG, enabled by the complementation of Escherichia coli murG(Ts) by the Mycobacterium tuberculosis homologue.
Jha RK; Katagihallimath N; Hota SK; Das KS; de Sousa SM
FEMS Microbiol Lett; 2012 Jan; 326(2):161-7. PubMed ID: 22092490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
